## BXP: BXP, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 1.7% below STRENGTH zone (4.0-10.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($68.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. State Street Corp Has $782.34 Million Position in BXP, Inc. $BXP**
- Source: MarketBeat | 20251213T132917 | Neutral | Relevance: 100%
- State Street Corp increased its stake in BXP, Inc. by 1.7% in Q2, boosting its holdings to 11,433,768 shares valued at $782.34 million. Despite institutional ownership nearing 99%, insider selling has been significant, with executives offloading shares worth over $5 million in the last three months. Analysts generally rate BXP as a "Hold" with a consensus price target of $79.25, after the company exceeded Q3 EPS and revenue expectations.

**2. Evaluating SL Green Realtyâ€™s valuation after strong 2025 Manhattan leasing momentum and rising investor optimism**
- Source: Simply Wall Street | 20251215T130956 | Neutral | Relevance: 65%
- SL Green Realty reported significant Manhattan office leasing in 2025, signaling strong momentum. Despite a recent share price recovery, the company's valuation remains a point of discussion, with a narrative fair value suggesting it is undervalued, while a price-to-sales analysis indicates it is expensive. The article explores both perspectives, considering future growth catalysts and potential risks.

**3. Empire State Realty OP Secures $210M Credit Facility**
- Source: MSN | 20251215T020942 | Somewhat-Bullish | Relevance: 63%
- Empire State Realty OP, a subsidiary of Empire State Realty Trust, has secured a $210 million credit facility. This financing is intended to support the company's financial operations and strategic initiatives.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Mizuho | $79 | $82 | -4% |
| 2025-12-04 | Keybanc | $80 | $0 | 0% |
| 2025-12-01 | Barclays | $78 | $79 | -1% |
| 2025-11-25 | Wells Fargo | $74 | $77 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Mizuho | main | Outperform |
| 2025-12-04 | Keybanc | up | Overweight |
| 2025-12-01 | Barclays | main | Equal-Weight |
| 2025-11-25 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.20M) |
| Sells | 6 ($5.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 15.2% (-1.4%)
- Blackrock Inc.: 11.2% (-8.7%)
- Tudor Investment Cor: 7.6% (+158588.2%)
- State Street Corpora: 7.1% (-1.1%)
- Cohen & Steers Inc.: 6.9% (+112.6%)

### Key Risks

1. Insider selling cluster: $5.1M in recent transactions.
2. Elevated short interest (8.8%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +6.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.30 indicates undervaluation relative to growth. Forward P/E 35.0x attractive for 184% earnings growth. Analyst sentiment negative (3 target cuts vs 0 raises). Insider selling cluster ($5.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.7B |
| Beta | 1.01 |
| 52W Range | $54.22 - $80.81 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.30 |
| Forward P/E | 35.0 |
| Current P/E | 99.5 |
| YoY Growth | 184.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -4.4% to 1.7% (+6.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.3pp (needs >4.0% for momentum thesis). MRS_5 at 2.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 54. OFD pattern: -SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.71% (CS: 49) | Neutral |
| RSI_14 | 53.6 | Neutral |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 1.015x | Above |
| vs SMA50 | 1.005x | Above |
| vs SMA200 | 1.034x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $71.62
- **Stop Loss:** $68.56 (4.3% risk)
- **Target:** $74.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 326
- **Position Value:** $23,348.12
- **Portfolio %:** 23.35%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-27 (Est: $0.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $-0.36 | -194.0% |
| 2025Q2 | $0.42 | $0.56 | +33.6% |
| 2025Q1 | $0.33 | $0.40 | +22.5% |
| 2024Q4 | $0.44 | $0.71 | +59.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*